Intravitreal Aflibercept in Neovascular AMD With Limited Response to Ranibizumab
Clinical trial NCT02309281 · COMPLETED
Trial details
- NCT number
- NCT02309281
- Sponsor
- Vista Klinik
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2013-05-01
- Primary completion
- 2014-05-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.